NCT00381472 - Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa | Biotech Hunter

Enrollment

393

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

December 31, 2004

Conditions

Parkinson Disease

Interventions

DRUG

Ropinirole

Trial Locations (76)

1083

GSK Investigational Site, Budapest

1096

GSK Investigational Site, Budapest

1135

GSK Investigational Site, Budapest

1145

GSK Investigational Site, Budapest

1204

GSK Investigational Site, Budapest

2020

GSK Investigational Site, Antwerp

2650

GSK Investigational Site, Edegem

3000

GSK Investigational Site, Leuven

3500

GSK Investigational Site, Hasselt

3526

GSK Investigational Site, Miskolc

3529

GSK Investigational Site, Miskolc

7623

GSK Investigational Site, Pécs

8800

GSK Investigational Site, Roeselare

10100

GSK Investigational Site, Turin

12205

GSK Investigational Site, Albany

13090

GSK Investigational Site, Aix-en-Provence

19013

GSK Investigational Site, Upland

19107

GSK Investigational Site, Philadelphia

27607

GSK Investigational Site, Raleigh

27705

GSK Investigational Site, Durham

28209

GSK Investigational Site, Charlotte

30329

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

30460

GSK Investigational Site, Pilsen

30912

GSK Investigational Site, Augusta

32405

GSK Investigational Site, Panama City

33486

GSK Investigational Site, Boca Raton

33606

GSK Investigational Site, Tampa

33701

GSK Investigational Site, St. Petersburg

36057

GSK Investigational Site, Vicenza

44791

GSK Investigational Site, Bochum

48025

GSK Investigational Site, Bingham Farms

48034

GSK Investigational Site, Southfield

49684

GSK Investigational Site, Traverse City

53233

GSK Investigational Site, Milwaukee

55043

GSK Investigational Site, Lido Di Camaiore (LU)

58100

GSK Investigational Site, Grosseto

59037

GSK Investigational Site, Lille

60025

GSK Investigational Site, Glenview

66160

GSK Investigational Site, Kansas City

75651

GSK Investigational Site, Paris

76301

GSK Investigational Site, Wichita Falls

80110

GSK Investigational Site, Englewood

86021

GSK Investigational Site, Poitiers

86077

GSK Investigational Site, Pozzilli (IS)

89102

GSK Investigational Site, Las Vegas

91325

GSK Investigational Site, Northridge

94109

GSK Investigational Site, San Francisco

35294-2041

GSK Investigational Site, Birmingham

02215

GSK Investigational Site, Boston

10029-6574

GSK Investigational Site, New York

43614-5809

GSK Investigational Site, Toledo

656 91

GSK Investigational Site, Brno

500 05

GSK Investigational Site, Hradec Králové

703 52

GSK Investigational Site, Ostrava

710 00

GSK Investigational Site, Ostrava

535 03

GSK Investigational Site, Pardubice

100 34

GSK Investigational Site, Prague

120 00

GSK Investigational Site, Prague

128 08

GSK Investigational Site, Prague

04103

GSK Investigational Site, Leipzig

Unknown

GSK Investigational Site, Vasvari Pal Street 2, H=9023 Gyor

15-276

GSK Investigational Site, Bialystok

66-212

GSK Investigational Site, Cibórz

80-211

GSK Investigational Site, Gdansk

80-308

GSK Investigational Site, Gdansk

40-752

GSK Investigational Site, Katowice

31-530

GSK Investigational Site, Krakow

64-100

GSK Investigational Site, Leszno

20-718

GSK Investigational Site, Lublin

20-954

GSK Investigational Site, Lublin

61-285 Poznań Ul.

GSK Investigational Site, Szwajcarska 3

87-100

GSK Investigational Site, Torun

01-337

GSK Investigational Site, Warsaw

02-097

GSK Investigational Site, Warsaw

08025

GSK Investigational Site, Barcelona